NEFROLOGÍA

1991

Artículos

Andrés A, Vázquez S, Cebrián M.P. Los nefrólogos como responsables de la donación de órganos: Experiencia en el Hospital 12 de Octubre. Nefrologia. 1991;11(Suppl. 1):32-4

Morales JM, Andrés A, Montoyo C, Ortuño B, Rodicio JL. Does calcium antagonist improve established early ciclosporin nephrotoxicity after renal transplantation? Nephron. 1991;57(2):227-9.

Morales JM, Campo C, Hernández E, Andrés A, Praga M, Montoyo C, et al. Influence of donor and recipient age on graft survival rate after renal transplantation with a protocol of low CyA doses. Transplant Proc. 1991;23(5):2622-3.

Praga M, Andrés A, Hernández E, Montoyo C, Mazuecos A, Campo C, et al. Tubular dysfunction in nephrotic syndrome: incidence and prognostic implications. Nephrol Dial Transplant. 1991;6(10):683-8.

Praga M, Borstein B, Andrés A, Arenas J, Oliet A, Montoyo C, et al. Nephrotic proteinuria without hypoalbuminemia: clinical characteristics and response to angiotensin-converting enzyme inhibition. Am J Kidney Dis. 1991;17(3):330-8.

Ruilope LM. Renal effects of nitrendipine. J Cardiovasc Pharmacol. 1991;18(Suppl 5):S10-3.

Ruilope LM, Guerrero L, Casal MC, Alcázar JM, Campo C, Mazuecos A, et al. Tolerance to nitrendipine in patients with arterial hypertension accompanying chronic renal failure. J Cardiovasc Pharmacol. 1991;18( Suppl 1):S71-3.

.

1992

Artículos

Alcázar JM, Mazuecos A, García Hidalgo E, Lázaro T, Ruilope LM, Rodicio JL. Insuficiencia renal e hipertensión vasculorrenal. Nefrologia. 1992;12(Suppl. 5):99-106

Andrés A, Morales JM, Farias J, Hernández G, Gómez M, Calleja J, et al. Acute renal failure after liver transplantation in patients treated with cyclosporine. Transplant Proc. 1992;24(1):126-7

Borrego L, Gil R, Mazuecos A, Ruiz R, López JL, Iglesias L. Cholesterol embolism to the skin. Clin Exp Dermatol. 1992;17(6):424-6

Campo C, Ruilope LM. Efecto de la dieta sobre la progresión de la insuficiencia renal. Nefrología. 1992;12(Suppl. 5):66-76

García Cantón C, Morales JM, Fernández Zataraín G, Andrés A, Sánchez R, Hernández G, et al. Importancia clínica del fracaso renal agudo en pacientes con trasplante hepático tratados con ciclosporina A. Nefrologia. 1992;12(Suppl. 4):223-8

Montoyo C, Martínez MA, Campo C, Mazuecos A, Andrés A, Praga M. Nephrotic syndrome and focal glomerulosclerosis in adult polycystic kidney disease. Nephron. 1992;61(1):106-10

Morales JM, Aguado JM, Díaz González R, Salto E, Andrés A, Campo C, et al. Alkaline-encrusted pyelitis/cystitis and urinary tract infection due to corynebacterium urealyticum: a new severe complication after renal transplantation. Transplant Proc. 1992;24(1):81-2

Morales JM, Andrés A, Montoyo C, Praga M, Alcázar JM, Algranati L, et al. Effect of captopril, an angiotensin converting enzyme inhibitor, on the massive proteinuria due to chronic rejection after renal transplantation—a prospective study. Transplant Proc. 1992;24(1):92-3

Morales JM, Andrés A, Montoyo C, Praga M, Hernández E, Alcázar J.M, et al. Efecto del captopril, un inhibidor de la enzima de conversión de la angiotensina en la proteinuria nefrótica del rechazo crónico del trasplante Renal. Un estudio prospectivo. Nefrologia. 1992;12(Suppl. 5):130-3

Morales JM, Andrés A, Rodríguez Paternina E, Alcázar JM, Montoyo C, Rodicio JL. Calcium antagonist therapy prevents chronic cyclosporine nephrotoxicity after renal transplantation: a prospective study. Transplant Proc. 1992;24(1):89-91.

Morales M, Campo C, Castellano G, Colina F, Andrés A, Fuertes A, et al. Clinical implications of the presence of antibodies to hepatitis C after renal transplantation. Transplant Proc. 1992;24(1):78-80

Morales JM, Praga M, Andrés A, Ortuño B, Rodicio JL. Fracaso renal agudo por ciclosporina A. Posible papel patogénico de las prostaglandinas. Nefrologia. 1992;12(Suppl. 4):205-9

Morales JM, Sancho S, Muñoz Cepeda MA, Andrés A, Campo C, Alcázar JM, et al. CyA monotherapy in patients over 50 years of age after renal transplantation: short-term results. Transplant Proc. 1992;24(1):37-8

Praga M. Fracaso renal agudo en las enfermedades glomerulares primitivas. Nefrologia. 1992;12(Suppl. 4):147-152

Praga M, Hernández E, Montoyo C, Andrés A, Ruilope LM, Rodicio JL. Long-term beneficial effects of angiotensin-converting enzyme inhibition in patients with nephrotic proteinuria. Am J Kidney Dis. 1992;20(3):240-8

Praga M, Hernández E, Rodicio JL. Efecto antiproteinúrico de los IECA. Influencia sobre la progresión de la Insuficiencia renal. Nefrologia. 1992;12(Suppl. 5):77-86

Prieto C, Pulido F, Rodríguez Paternina E, Algranati C, Bello I, Farias J, et al. Late acute rejection in renal transplant recipients: response to steroid treatment. Transplant Proc. 1992;24(1):35-6.

Rodicio JL, Alcázar JM, Ruilope LM. The antihypertensive effect of verapamil in patients with chronic renal failure. J Hum Hypertens. 1992;6 Suppl 2:S41-3

Rodríguez Antolín A, Morales JM, Andrés A, Fernández Aparicio T, Díaz González R, Pamplona M, et al. Treatment of erectile impotence in renal transplant patients with intracavernosal vasoactive drugs. Transplant Proc. 1992;24(1):105-6

Ruilope LM, Alcázar JM, Rodicio JL. Renal consequences of arterial hypertension. J Hypertens Suppl. 1992;10(7):S85-90

Ruilope LM, Casal MC, Guerrero L, Alcázar JM, Fernández ML, Lahera V, Et al. Sodium intake does not influence the effect of verapamil in hypertensive patients with mild renal insufficiency. Drugs. 1992;44 Suppl 1:94-8

Ruilope LM, Casal MC, Praga M, Alcázar JM, Decap G, Lahera V, Rodicio JL. Additive antiproteinuric effect of converting enzyme inhibition and a low protein intake. J Am Soc Nephrol. 1992;3(6):1307-11

Sánchez R, Alcázar JM, Mazuecos A, Campos C, Mosquera J.R, Praga M, et al. Tratamiento del fracaso renal agudo en pacientes con fallo multiorgánico mediante hemodiálisis continua. Nefrologia. 1992;12(Suppl. 4):301-5

.

1993

Artículos

Aguado JM, Morales JM, Salto E, Lumbreras C, Lizasoaín M, Díaz-González R, et al. Encrusted pyelitis and cystitis by Corynebacterium urealyticum (CDC group D2): a new and threatening complication following renal transplant. Transplantation. 1993 Sep;56(3):617-22

Aguado JM, Salto E, Morales JM, Muñoz MA, Lizasoaín M, Lumbreras C, et al. Corynebacterium urealyticum: a new and threatening pathogen for the renal transplant patient. Transplant Proc. 1993;25(1 Pt 2):1493-4

Andrés Belmonte A. Selection of suboptimal donors. Transplantology. 1993;4(4):97-102

Araque A, Mazuecos A, Andrés A, Sánchez R, Ortuño T, Praga M. Tratamiento con esteroides y clorambucil de las glomerulonefritis membranosas idiopáticas con insuficiencia renal progresiva. Nefrologia. 1993;13(4):350-5

Hernández E, Praga M, Alcázar JM, Morales JM, Montejo JC, Jiménez MJ, Et al. Hemodialysis for treatment of accidental hypothermia. Nephron. 1993;63(2):214-6

Mazuecos AM, Praga M, Araque A, Hernández E, Sánchez R, Andrés A, et al. Evolución a largo plazo de las glomerulonefritis membranosas idiopáticas no tratadas. Nefrologia. 1993;13(4):299-305

Mazuecos A, Ramos Guillén PC, Campo C, Sánchez R, Martínez MA, Praga M. Chronic renal insufficiency after an episode of macroscopic hematuria in IgA nephropathy. Nephron. 1993;64(3):452-5

Morales JM, Muñoz MA, Castellano G, Colina F, Fuertes A, Andrés A, et al. Impact of hepatitis C in long-functioning renal transplants: a clinicopathological follow-up. Transplant Proc. 1993;25(1 Pt 2):1450-3

Morales Cerdán JM, Castellano G, Colina F, Andrés A, Muñoz MA, Hernández E, et al. Evolución clínico-patológica de la hepatitis c tras el trasplante renal. Nefrologia. 1993;13(5):493-9

Rodicio JL, Morales JM, Alcázar JM, Ruilope LM. Calcium antagonists and renal protection. J Hypertens Suppl. 1993;11(1):S49-53.

Rodicio JL, Morales JM, Ruilope LM. Lipophilic dihydropyridines provide renal protection from cyclosporin toxicity. J Hypertens Suppl. 1993;11(6):S21-5.

Rodicio JL, Ruilope LM. Angiotensin-converting enzyme inhibitors in the treatment of mild arterial hypertension. Clin Exp Hypertens. 1993;15(6):1277-89.

Ruilope LM. Kidney and aetiology, pathology and management of essential hypertension. J Hum Hypertens. 1993;7(Suppl 1):S37-S41

Ruilope LM. The course of chronic renal failure and therapeutic intervention: Clinical studies. Cardiovascular Risk Factors. 1993;3(3):181-7

Ruilope LM, Araque A, Lahera V, Suarez C. Antihypertensive effect of nitrendipine in the hypertensive patient with renal impairment. Ren Fail. 1993;15(3):359-63.

Ruilope LM, Campo C, Lahera V. The kidney and arterial hypertension. Drugs. 1993;46(Suppl 2):108-12.

Ruilope LM, Lahera V. Influence of salt intake on the antihypertensive effect of carvedilol. J Hypertens Suppl. 1993;11(4):S17-9.

Ruilope LM, Rodicio JL. Clinical relevance of proteinuria and microalbuminuria. Curr Opin Nephrol Hypertens. 1993;2(6):962-7.

Sánchez R, Praga M, Rivas Salas JJ, Araque A, Mazuecos A, Andrés A, et al. Compressive myelopathy due to dialysis-associated amyloidosis. Nephron. 1993;65(3):463-5.

.

1994

Artículos

Andrés A, Mazuecos A, Morales JM, Praga M, Martínez MA, Usera G, et al. Renal allograft infarction is a cause of early kidney transplant loss in the cyclosporine A era. Transplant Proc. 1994;26(5):2544-5.

Aranda Arcas JL, Sánchez R, Guijarro C, Araque A, Pulido F, Praga M, et al. Efecto de la pravastatina en la hipercolesterolemia asociada a proteinuria. An Med Interna. 1994;11(11):523-7

Hernández Martínez E, Oliet A. Estudio cooperativo de nutrición en hemodiálisis I. Material y métodos. Nefrologia. 1994;14(Supl 2):31-5

Mazuecos A, Andrés A, Sánchez R, Araque A, Villena MV, De Prada I, et al. Enfermedad de wegener con inicio exclusivamente renal. Nefrologia. 1994;14(3):345-50

Morales JM, Muñoz MA, Campo C, Andrés A, Araque A, Álamo C, et al. Renal transplantation in older patients with doublé therapy with optional change to cyclosporine monotherapy: long-term results. Transplant Proc. 1994;26(5):2511-2

Pablos JL, Gutiérrez Millet V, Gómez Reino JJ. Remission of lupus nephritis with cyclophosphamide and late relapses following therapy withdrawal. Scand J Rheumatol. 1994;23(3):142-4.

Rodicio JL. Clinical experience in the treatment of nondiabetic renal disease: Summary and concluding remarks. Kidney Int Suppl. 1994;45:S179-S180

Rosa C, Cisneros E, Alcázar JM, Praga M. Glomerulonefritis membranosa como primera manifestación de una sarcoidosis. Nefrologia. 1994;14(5):602-5

Ruilope LM. Comparison of a new vasodilating beta-blocker, carvedilol, with atenolol in the treatment of mild to moderate essential hypertension. Am J Hypertens. 1994;7(2):129-36. Erratum in: Am J Hypertens 1994 Apr;7(4 Pt 1):379.

Ruilope LM. How much does the kidney participate in the origin of primary hypertension? Blood Press. 1994;3(4):216-8.

Ruilope LM, Alcázar JM, Hernández E, Praga M, Lahera V, Rodicio JL. Long-term influences of antihypertensive therapy on microalbuminuria in essential hypertension. Kidney Int Suppl. 1994;45:S171-3.

Ruilope LM, Campo C, Rodicio JL. Relationship between blood pressure and renal function. J Hypertens Suppl. 1994;12(8):S55-9.

Ruilope LM, Lahera V, Alcázar JM, Praga M, Campo C, Rodicio JL. Randomly allocated study of the effects of standard therapy versus ACE inhibition on micro-albuminuria in essential hypertension. J Hypertens Suppl. 1994;12(4):S59-63.

Ruilope LM, Lahera V, Araque A, Suárez C, Rodicio JL, Romero JC. Electrolyte excretion and sodium intake. Am J Med Sci. 1994;307(Suppl 1):S107-11.

Ruilope LM, Lahera V, Rodicio JL. Evaluation of the renal effects of calcium antagonists. J Cardiovasc Pharmacol. 1994;23(Suppl 5):S49-53.

Ruilope LM, Lahera V, Rodicio JL, Carlos Romero J. Are renal hemodynamics a key factor in the development and maintenance of arterial hypertension in humans? Hypertension. 1994;23(1):3-9.

.

1995

Artículos

Araque A, Sánchez R, Álamo C, Torres N, Praga M. Evolution of immunoglobulin A nephropathy into Henoch-Schönlein purpura in an adult patient. Am J Kidney Dis. 1995;25(2):340-2

García Bravo M, Aguado JM, Morales JM, Hayek M, Díaz González R, Gimeno Fernández C, et al. Corynebacterium urealyticum en pacientes con transplante renal. Med Clin (Barc). 1995;104(15):561-4

Hernández E, Morales JM, Andrés A, Ortuño B, Praga M, Alcázar JM, et al. Usefulness and safety of treatment with captopril in posttransplant erythrocytosis. Transplant Proc. 1995;27(4):2239-41

Mazuecos A, Núñez V, Gómez B, Manrique A, Andrés A, Hidalgo E, et al. Usefulness of isotopic renography with captopril in the diagnosis of transplant renal artery stenosis. Transplant Proc. 1995;27(4):2242-3

Melero M, Rodríguez M, Araque A, Álamo C, Andrés A, Praga M. Idiopathic dialysis ascites in the nineties: resolution after renal transplantation. Am J Kidney Dis. 1995;26(4):668-70

Morales JM. Hepatitis C and renal transplantation: outcome of patients. Nephrol Dial Transplant. 1995;10(Suppl 6):125-8

Morales JM, Campistol JM, Castellano G, Andrés A, Colina F, Fuertes A, Ercilla G, et al. Transplantation of kidneys from donors with hepatitis C antibody into recipients with pre-transplantation anti-HCV. Kidney Int. 1995;47(1):236-40.

Morales JM, Muñoz MA, Fernández Zataraín G, García Cantón C, García Rubiales MA, Andrés A, et al. Reversible acute renal failure caused by the combined use of foscarnet and cyclosporin in organ transplanted patients. Nephrol Dial Transplant. 1995;10(6):882-3.

Praga M, Hernández E, Andrés A, León M, Ruilope LM, Rodicio JL. Effects of body-weight loss and captopril treatment on proteinuria associated with obesity. Nephron. 1995;70(1):35-41.

Praga M, Vara J, González Parra E, Andrés A, Álamo C, Araque A, et al. Familial hypomagnesemia with hypercalciuria and nephrocalcinosis. Kidney Int. 1995;47(5):1419-25.

Rodicio JL, Ruilope LM. Assessing renal effects and renal protection. J Hypertens Suppl. 1995;13(4):S19-25.

Ruilope LM. Effects of angiotensin converting enzyme inhibitors on the progression of diabetic nephropathy. J Hypertens Suppl. 1995;13(2):S91-3.

Ruilope LM. The hidden truth: what do the clinical trials really tell us about BP control? J Hum Hypertens. 1995;9(Suppl 2):S3-7.

.

1996

Artículos

Bornstein B, Arenas J, Morales JM, Praga M, Rodicio JL, Martinez A, Valdivieso L. Cyclosporine nephrotoxicity and rejection crisis: diagnosis by urinary enzyme excretion. Nephron. 1996;72(3):402-6.

Campo C, Lahera V, García Robles R, Cachofeiro V, Alcázar JM, Andrés A, et al. Aging abolishes the renal response to L-arginine infusión in essential hypertension. Kidney Int Suppl. 1996;55:S126-8.

García Bravo M, Aguado JM, Morales JM, Noriega AR. Influence of external factors in resistance of Corynebacterium urealyticum to antimicrobial agents. Antimicrob Agents Chemother. 1996;40(2):497-9.

Hernández E, Praga M, Álamo C, Araque A, Morales JM, Alcázar JM, et al. Lipoprotein(a) and vascular access survival in patients on chronic hemodialysis. Nephron. 1996;72(2):145-9.

Mazuecos A, Araque A, Sánchez R, Martínez MA, Güesmes A, Rivero M, et al. Systemic amyloidosis secondary to pyonephrosis. Resolution after nephrectomy. Nephrol Dial Transplant. 1996;11(5):875-8.

Morales JM. Management and prevention of acute renal failure in solid organ transplantation. Ren Fail. 1996;18(3):481-8.

Morales JM, Rodicio JL. Should hepatitis C positive donors be accepted for renal transplantation? Curr Opin Nephrol Hypertens. 1996;5(3):199-201.

Rodicio JL. Can the kidney prevent cardiovascular diseases? Clin Exp Hypertens. 199618(3-4):501-11.

Rodicio JL. Does antihypertensive therapy protect the kidney in essential hypertension? J Hypertens Suppl. 1996;14(2):S69-75; discussion S75-6.

Rodicio JL. Renal effects of calcium antagonists with special reference to manidipine hydrochloride. Blood Press Suppl. 1996;5:10-5

Ruilope LM, Hansson L, Zanchetti A. Renal aspects of the hypertension optimal treatment (HOT) study. J Nephrol. 1996;9(3):147-151

Ruilope LM, Rodicio JL. Hypertension, atherosclerosis and microalbuminuria in ELSA. European Lacidipine Study of Atherosclerosis. Blood Press Suppl. 1996;4:48-52.

Ruilope LM, Simpson RL, Toh J, Arcuri KE, Goldberg AI, Sweet CS. Controlled trial of losartan given concomitantly with different doses of hydrochlorothiazide in hypertensive patients. Blood Press. 1996;5(1):32-40.

.

1997

Artículos

Alcázar JM, Caramelo CA, Alegre ER, Abad J. Ischaemic renal injury. Curr Opin Nephrol Hypertens. 1997;6(2):157-65.

Andrés A, Morales JM, Praga M, Campo C, Lahera V, García Robles R, et al. L-arginine reverses the antinatriuretic effect of cyclosporin in renal transplant patients. Nephrol Dial Transplant. 1997;12(7):1437-40

Brown MJ, Castaigne A, De Leeuw PW, Mancia G, Rosenthal T, Ruilope LM. INSIGHT – study rationale and design. Int J Clin Pract Suppl. 1997;(92):39-40

Campo C, García Vallejo O, Barrios V, Lahera V, Manero M, Esteban E, et al. The natriuretic effect of nifedipine gastrointestinal therapeutic system remains despite the presence of mild-to-moderate renal failure. J Hypertens. 1997;15(12 Pt 2):1803-8

García Bravo M, Aguado JM, Morales JM, Rodríguez Noriega A. Efficacy of a selective and differential medium for isolating corynebacterium urealyticum from urine specimens. Clin Microbiol Infect. 1997;3(5):555-8

Hernández E, Toledo T, Álamo C, Mon C, Rodicio JL, Praga M. Elevation of von Willebrand factor levels in patients with IgA nephropathy: effect of ACE inhibition. Am J Kidney Dis. 1997;30(3):397-403.

Morales E, Alegre R, Herrero JC, Morales JM, Ortuño T, Praga M. Hepatitis-C-virus-associated cryoglobulinaemic membranoproliferative glomerulonephritis in patients infected by HIV. Nephrol Dial Transplant. 1997;12(9):1980-4.

Morales JM, Campistol JM, Andrés A, Rodicio JL. Glomerular diseases in patients with hepatitis C virus infection after renal transplantation. Curr Opin Nephrol Hypertens. 1997;6(6):511-5.

Morales JM, Martínez MA, Muñoz de Bustillo E, Muñoz MA, Gota R, Usera G. Recurrent type III membranoproliferative glomerulonephritis after kidney transplantation. Transplantation. 1997;63(8):1186-8.

Morales JM, Pascual Capdevila J, Campistol JM, Fernández Zatarain G, Muñoz MA, Andrés A, et al. Membranous glomerulonephritis associated with hepatitis C virus infection in renal transplant patients. Transplantation. 1997;63(11):1634-9

Praga M. Progresión de la insuficiencia renal crónica en el paciente geriátrico. Nefrologia. 1997;17(Supl 3):68-72

Praga M, Paz Artal E, Hernández E, Segura J, Moreno MA, Morales JM, et al. Antiproteinuric effect of angiotensin-converting enzyme inhibition and C5b-9 urinary excretion in membranous glomerulonephritis. Nephrol Dial Transplant. 1997;12(12):2576-9

Rodicio JL. Introduction. J Hypertens Suppl. 1997;15(2):S1

Ruilope L. Human pharmacokinetic/pharmacodynamic profile of irbesartan: a new potent angiotensin II receptor antagonist. J Hypertens Suppl. 1997;15(7):S15-20.

Ruilope LM. Microalbuminuria as risk in essential hypertension. Nephrol Dial Transplant. 1997;12 Suppl 2:2-5

Ruilope LM. Microalbuminuria in non-diabetic hypertensive patients: Incidence, prevalence and value in predicting clinical outcome. Int J Clin Pract Suppl. 1997;(92):46-51

Ruilope LM. Prevalence of renal disease in elderly hypertensive patients with cardiovascular problems. Coron Artery Dis. 1997;8(8-9):483-8.

Ruilope LM. Relationship between cardiac hypertrophy and microalbuminuria. Adv Exp Med Biol. 1997;432:135-43.

Ruilope LM. Renal implications of arterial hypertension. Curr Opin Nephrol Hypertens. 1997;6(2):152-6.

Ruilope LM. Renoprotection and renin-angiotensin system blockade in diabetes mellitus. Am J Hypertens. 1997;10(12 Pt 2):325S-331S.

Ruilope LM, García Robles R. How far should blood pressure be reduced in diabetic hypertensive patients? J Hypertens Suppl. 1997;15(2):S63-5.

Ruilope LM, Suárez C. How should we treat hypertensive women with cardiac and renal impairment? Am J Hypertens. 1997;10(10 Pt 2):242S-246S.

.

1998

Artículos

Alcázar de la Osa JM, Fernández Valenzuela V, Rodríguez de la Calle J, Vidal Barraquer Mayol F. Patología aneurismática de la arteria renal. Angiologia. 1998;50(6):257-68

Alcázar de la Osa JM, Fernández Valenzuela V, Rodríguez de la Calle J, Vidal Barraquer Mayol F. Patología obstructiva de la arteria renal. Angiologia. 1998;50(6):269-84

Andrés A, Herrero JC, Praga M, Segura J, Rodicio JL, Morales JM. Trasplante renal con donantes de edad avanzada. Nefrologia. 1998;18(Supl 5):50-8

Fernández Miranda C, De la Calle A, Morales JM, Guijarro C, Aranda JL, Gómez Sanz R, et al. Lipoprotein abnormalities in long-term stable liver and renal transplanted patients. A comparative study. Clin Transplant. 1998;12(2):136-41. Erratum in: Clin Transplant 1998;12(5):487.

González Albarrán O, García Robles R, Ruilope LM. Therapeutic implications and new perspectives for essential hypertension and renal damage. Kidney Int Suppl. 1998;68:S46-50.

Manzanares C, Moreno M, Castellanos F, Cubas A, Herrero JC, Morales Ruiz E, et al. Influence of hepatitis C virus infection on FK 506 blood levels in renal transplant patients. Transplant Proc. 1998;30(4):1264-5.

Morales JM, Campistol JM, Andrés A, Rodicio JL. Hepatitis C virus and renal transplantation. Curr Opin Nephrol Hypertens. 1998;7(2):177-83

Morales JM, Domingo MJ, Losada P, Fuertes A, Andrés A, Castellano G, et al. Hepatopatía por virus C en pacientes con transplante renal. Nefrologia. 1998;18(Supl 1):60-9

Muñoz de Bustillo E, Ibarrola C, Andrés A, Colina F, Morales JM. Hepatitis-B-virus-related fibrosing cholestatic hepatitis after renal transplantation with acute graft failure following interferon-alpha therapy. Nephrol Dial Transplant. 1998;13(6):1574-6.

Muñoz de Bustillo E, Ibarrola C, Colina F, Castellano G, Fuertes A, Andrés A, et al. Fibrosing cholestatic hepatitis in hepatitis C virus-infected renal transplant recipients. J Am Soc Nephrol. 1998;9(6):1109-13

Praga M. New insights into familial microhematuria. Curr Opin Nephrol Hypertens. 1999;8(2):173-7

Praga M. Tratamiento de las glomerulonefritis crónicas. Nefrologia. 1998;18(Supl 6):52-61

Praga M, Martínez MA, Andrés A, Alegre R, Vara J, Morales E, et al. Association of thin basement membrane nephropathy with hypercalciuria, hyperuricosuria and nephrolithiasis. Kidney Int. 1998;54(3):915-20

Praga M, Morales E, Herrero JC, Revilla Y, Bell I, González RD. Disminución de la masa renal funcionante y proteinuria. Nefrologia. 1998;18(Supl 1):17-22

Rodicio JL. Brief history of the Spanish Society and League Against Hypertension. Am J Kidney Dis. 1998;32(1):xliii-xlv.

Rodicio JL, Campo C, Ruilope LM. Microalbuminuria in essential hypertension. Kidney Int Suppl. 1998;68:S51-4.

Ruilope LM, Coca A. The role of combination therapy in the treatment of hypertension. Blood Press Suppl. 1998;1:22-6.

Ruilope LM, García Robles R. How to treat the diabetic hypertensive individual appropriately. J Hypertens Suppl. 1998;16(1):S91-3.

Serrano R, Martínez MA, Andrés A, Morales JM, Samartin R. Familial mediterranean fever and acute myocardial infarction secondary to coronary vasculitis. Histopathology. 1998;33(2):163-7.

.

1999

Artículos

Andrés A, Herrero JC, Morales E, Praga M, Vázquez S, Vereda M, Cebrián P, Rodicio JL, Morales JM, Aguirre F, Diaz R, Polo G, Leiva O. The double or single renal graft depending on the percentage of glomerulosclerosis in the preimplant biopsy reduces the number of discarded kidneys from donors older than 60 years. Transplant Proc. 1999;31(6):2285-6.

Andrés A, Sánchez Casado M, Cebrián P, Vereda M, Vázquez S, Morales E, Ramos A, Escudero L, Montejo JC, Montero A, Alted E. Very old patients with spontaneous cerebral hemorrhage are an important group of potential organ donors. Transplant Proc. 1999;31(6):2593-4

Campistol JM, Mazuecos A, Segura J, Osuna A, Herrero JC, Andrés A, Oppenheimer F, Gómez de la Camara A, Martínez MA, Morales JM. Mycophenolate mofetil slows the decline of renal function in patients with biopsy-proven chronic rejection: a collaborative pilot study. Transplant Proc. 1999;31(6):2267-9.

Caramelo C, Bello E, Ruiz E, Rovira A, Gazapo RM, Alcázar JM, Martell N, Ruilope LM, Casado S, Fernández Guerrero M. Hyperkalemia in patients infected with the human immunodeficiency virus: involvement of a systemic mechanism. Kidney Int. 1999;56(1):198-205.

Cubas A, Herrero JC, Morales E, Carreño A, Domínguez Gil B, Cirujeda A, Praga M, Ortuño T, Hernández E, Delgado M, Andrés A, Morales JM. The early impact of mycophenolate mofetil in combination with steroids and cyclosporine Neoral after renal transplantation: a six-month analysis. Transplant Proc. 1999;31(6):2265-6.

Delgado J, Muñoz de Bustillo E, Ibarrola C, Colina F, Morales JM, Rodríguez E, Aguado JM, Fuertes A, Gómez MA. Hepatitis C virus-related fibrosing cholestatic hepatitis after cardiac transplantation: is azathioprine a contributory factor? J Heart Lung Transplant. 1999;18(6):607-10.

Domínguez Gil B, Herrero JC, Carreño A, Morales E, Andrés A, Aguado JM, Díaz González R, Benito A, Morales JM. Ureteral stenosis secondary to encrustation by urea-splitting Corynebacterium urealyticum in a kidney transplant patient. Nephrol Dial Transplant. 1999;14(4):977-8.

Fernández Aparicio T, Miñana López B, Polo Villar G, Díaz González R, Fraile Gómez B, Aguirre Benitez F, Morales Cerdán JM, Leiva Galvis O. Influencia de la trasplantectomía del primer injerto en la evolución del retrasplante renal de cadáver. Actas Urol Esp. 1999;23(10):864-72.

Herrero JC, Andrés A, Praga M, Morales E, Domínguez Gil B, Carreño A, Hernández E, Morales JM. Long-term results of renal transplants from donors older than 60 years. Transplant Proc. 1999;31(6):2281-2.

Herrero JC, Morales E, Domínguez Gil B, Carreño A, Cubas A, Andrés A, Praga M, Ortuño T, Hernández E, Rodicio JL, Morales JM. Mycophenolate mofetil, cyclosporine, and steroids after renal transplantation: five-year results at a single center. Transplant Proc. 1999;31(6):2263-4

Morales JM. Hepatitis C virus infection and renal transplantation. Transplant Proc. 1999;31(6):2221-4.

Morales E, Andrés A, Herrero JC, Domínguez Gil B, Carreño A, Morales JM, Hernández E, Ortuño T, Praga M. Conversion from cyclosporine to FK 506 as rescue therapy in renal transplantation with poorly steroid-responsive acute rejection. Transplant Proc. 1999;31(6):2248-9.

Morales JM, Andrés A, Morales E, Herrero JC, Cubas A, Praga M, Hernández E, Ortuño T, Domínguez Gil B, Carreño A, Delgado M, Manzanares C. Tacrolimus, mycophenolate mofetil and corticosteroids as primary immunosuppression after renal transplantation at the Hospital 12 de Octubre, Madrid. Transplant Proc. 1999;31(7A):75S-77S

Morales E, Hernández E. La enfermedad renal en la esclerosis sistémica.  Rev Esp Reumatol. 1999;26(6):219-25

Morales E, Herrero JC, Domínguez Gil B, Carreño A, Usera G, Praga M. The unusual diabetic patient with advanced renal insufficiency on ACE inhibitors. What is the explanation for her persisting hypokalaemia? Nephrol Dial Transplant. 1999;14(5):1313-4.

Moreno M, Latorre A, Manzanares C, Morales E, Herrero JC, Domínguez Gil B, Carreño A, Cubas A, Delgado M, Andrés A, Morales JM. Clinical management of tacrolimus drug interactions in renal transplant patients. Transplant Proc. 1999;31(6):2252-3

Morales JM, Morales E, Andrés A, Praga M. Glomerulonephritis associated with hepatitis C virus infection. Curr Opin Nephrol Hypertens. 1999;8(2):205-11

Praga M, Morales E, Herrero JC, Pérez Campos A, Domínguez Gil B, Alegre R, Vara J, Martínez MA. Absence of hypoalbuminemia despite massive proteinuria in focal segmental glomerulosclerosis secondary to hyperfiltration. Am J Kidney Dis. 1999;33(1):52-8.

Ruilope LM. Is it wise to combine an ACE inhibitor and an angiotensin receptor antagonist? Nephrol Dial Transplant. 1999;14(12):2855-6.

Ruilope LM. The kidney as part of the cardiovascular system. J Cardiovasc Pharmacol. 1999;33 Suppl 1:S7-10; discussion S41-S43

Ruilope LM, Barrios V, Segura J, Campo C. The kidney in heart failure: Role of angiotensin II. Curr Opin Nephrol Hypertens. 1999;8(2):153-6

Ruilope LM, De la Sierra A, Moreno E, Fernández R, Garrido J, De la Figuera M, Gómez de la Cámara A, Coca A, Luque Otero M. Prospective comparison of therapeutical attitudes in hypertensive type 2 diabetic patients uncontrolled on monotherapy. A randomized trial: the EDICTA study. J Hypertens. 1999;17(12 Pt 2):1917-23.

Ruilope LM, Rodicio JL. Renal surrogates in essential hypertension. Clin Exp Hypertens. 1999;21(5-6):609-14

Sánchez V, Delgado JF, Blasco T, Dalmau R, Morales JM, Escribano P, Tello R, Hernández J, Velázquez T, Sotelo T, Gómez-Sánchez MA, Sáenz de la Calzada C. Benefits of mycophenolate mofetil in cardiac transplant recipients with cyclosporine-induced nephropathy. Transplant Proc. 1999;31(6):2515-6

Suárez C, Ruilope LM. Una nueva guía de la Organización Mundial de la Salud y la Sociedad Internacional de Hipertensión para el manejo de la hipertensión arterial: Hacia una guía común. Rev Esp Cardiol. 1999;52(6):381-2

.

2000

Artículos

Alcázar J, Rodicio J. Hypertension and ischemic nephropathy. Curr Hypertens Rep. 2000;2(4):343-4.

Alcázar JM, Rodicio JL. Ischemic nephropathy: clinical characteristics and treatment. Am J Kidney Dis. 2000;36(5):883-93.

Andrés A, Morales JM, Herrero JC, Praga M, Morales E, Hernández E, Ortuño T, Rodício JL, Martínez MA, Usera G, Díaz R, Polo G, Aguirre F, Leiva O. Double versus single renal allografts from aged donors. Transplantation. 2000;69(10):2060-6

Campistol JM, Esforzdo N, Barrera JM, Morales JM, Oppenheimer F. Hepatitis C virus-positive patients on the waiting list for transplantation: study, evaluation and treatment. Nephrol Dial Transplant. 2000;15 Suppl 8:68-70 [doi

Campo C, Fernández G, González Esteban J, Segura J, Ruilope LM; ESPADA Study Group. Comparative study of home and office blood pressure in hypertensive patients treated with enalapril/HCTZ 20/6 mg: the ESPADA study. Blood Press. 2000;9(6):355-62.

Carreño A, Morales E, Domínguez Gil B, Herrero JC, Ortiz M, González E, Praga M. The patient with over 100 relapses of minimal change nephrotic syndrome: prolonged complete remission after chlorambucil treatment. Nephrol Dial Transplant. 2000;15(6):922-923

Cea Calvo L, Lozano F, Pombo M, Serrano A, Rodríguez E, Porto J, Pozuelo A, González C. Images in cardiovascular medicine. Uterine intravenous leiomyomatosis extending through the inferior vena cava into the right cardiac cavities. Circulation. 2000;101(5):581-3

De la Sierra A, Ruilope LM, Coca A, Luque Otero M. Relación entre el perfil de riesgo cardiovascular y la selección y utilización de los fármacos antihipertensivos. GEDEC (Grupo Español de Estudios Cardiovasculares). Med Clin (Barc). 2000;115(2):41-5 [doi]

Domínguez Gil B, Hernández E, Carreño A, González E, Ortiz M, Sierra MP, Rodicio JL, Praga M. Peculiaridades diagnósticas y evolutivas de la glomerulonefritis membranosa lípica. Nefrologia. 2000;20(6):523-31

Escribá A, Morales E, Albizúa E, Herrero JC, Ortuño T, Carreño A, et al. Secondary (AA-type) amyloidosis in patients with polymyalgia rheumatica. Am J Kidney Dis. 2000;35(1):137-40

Escribano Subías P, López-Ríos F, Delgado Jiménez JF, Sotelo Rodríguez T, Aguado JM, Rodríguez Hernández E. Aneurisma micótico por Aspergillus en la línea de sutura aórtica tras el trasplante cardíaco. Rev Esp Cardiol. 2000;53(10):1403-5

Fagard RH, Staessen JA, Thijs L, Gasowski J, Bulpitt CJ, Clement D, et al. Response to antihypertensive therapy in older patients with sustained and nonsustained systolic hypertension. Systolic Hypertension in Europe (Syst-Eur) Trial Investigators. Circulation. 2000;102(10):1139-44 [doi

Fernández Aparicio T, Miñana López B, Polo Villar G, Díaz González R, Fraile Gómez B, Aguirre Benites F, Morales Cerdán JM, Leiva Galvis O. Compatibilidad HLA y reexposicion antigenica. Influencia en la evolucion del retrasplante renal de cadáver. Arch Esp Urol. 2000;53(1):53-64.

Fernández Miranda C, De la Calle M, Larumbe S, Gómez Izquierdo T, Porres A, Gómez Gerique J, Enríquez de Salamanca R. Lipoprotein abnormalities in patients with asymptomatic acute porphyria. Clin Chim Acta. 2000;294(1-2):37-43.

Fernández Miranda C, Gómez P, Díaz Rubio P, Estenoz J, Carillo JL, Andrés A, et al. Plasma homocysteine levels in renal transplanted patients on cyclosporine or tacrolimus therapy: effect of treatment with folic acid. Clin Transplant. 2000;14(2):110-4 [doi

Gomez Martin C, Solá C, Hornedo J, Perea S, Lumbreras C, Valentí V, Arcediano A, Rodríguez M, Salazar R, Cortés Funes H, Hidalgo M. Rifampin does not improve the efficacy of quinolone antibacterial prophylaxis in neutropenic cáncer patients: results of a randomized clinical trial. J Clin Oncol. 2000;18(10):2126-34

González E, Rada MA, Lumbreras C, Ramos JT, Aguado JM. Seguridad de la anfotericina B liposomal en pacientes con elevado riesgo de nefrotoxicidad. Enferm Infecc Microbiol Clin. 2000;18(4):162-4

Hernández G, Arriba L, Lucas M, De Andrés A. Reduction of severe gingival overgrowth in a kidney transplant patient by replacing cyclosporin A with tacrolimus. J Periodontol. 2000;71(10):1630-6 [doi]

Jiménez JS, Martín I, De la Fuente L, Muñoz JL, Vaquero G, Ramírez M, Pérez C, De La Fuente P. Severe menorrhagia due to Glanzmann thrombasthenia treated with hydrothermal ablation. J Am Assoc Gynecol Laparosc. 2000;7(2):265-7

Kreis H, Cisterne JM, Land W, Wramner L, Squifflet JP, Abramowicz D, et al. Sirolimus in association with mycophenolate mofetil induction for the prevention of acute graft rejection in renal allograft recipients. Transplantation. 2000;69(7):1252-60 [doi

Maeso R, Aragoncillo P, Navarro Cid J, Ruilope LM, Diaz C, Hernández G, Lahera V, Cachofeiro V. Effect of atorvastatin on endothelium-dependent constrictor factors in dyslipidemic rabbits. Vasc Pharmacol. 2000;34(4):263-72

Morales JM, Campistol JM. Transplantation in the patient with hepatitis C. J Am Soc Nephrol. 2000;11(7):1343-53

Morales JM, Campistol JM, Andrés A, Domínguez Gil B, Esforzado N, Muñoz MA, Bruguera M, Oppenheimer F, Rodicio JL. Policies concerning the use of kidneys from donors infected with hepatitis C virus. Nephrol Dial Transplant. 2000;15(Suppl 8):71-3

Morales JM, Campistol JM, Andrés A, Herrero JC. Immunosuppression in older renal transplant patients. Drugs Aging. 2000;16(4):279-87

Praga M. Nefropatía por hiperfiltración. Nefrologia. 2000;20(4):311-35

Praga M, Alegre R, Hernández E, Morales E, Domínguez Gil B, Carreño A, Andrés A. Familial microscopic hematuria caused by hypercalciuria and hyperuricosuria. Am J Kidney Dis. 2000;35(1):141-5

Praga M, Hernández E, Herrero JC, Morales E, Revilla Y, Díaz González R, Rodicio JL. Influence of obesity on the appearance of proteinuria and renal insufficiency after unilateral nephrectomy. Kidney Int. 2000;58(5):2111-8

Praga Terente M. Anomalías del transporte paracelular y bases genéticas del síndrome de hipomagnesemia, hipercalciuria y nefrocalcinosis. Rev Esp Enferm Metab Oseas. 2000;9(4):135-6

Rodicio JL. Calcium antagonists and renal protection from cyclosporine nephrotoxicity: long-term trial in renal transplantation patients. J Cardiovasc Pharmacol. 2000;35(3 Suppl 1):S7-11 [doi]

Ruilope LM. Antihypertensive treatment of patients with diabetes and venal dysfunction: the INSIGHT trial. Eur Heart J Suppl. 2000;2:D):31-32

Ruilope LM. AT1-receptor blockers and ACE inhibitors: alternatives or partners? Int J Clin Pract Suppl. 2000;(111):20-4.

Ruilope LM. Do we effectively lower blood pressure? J Cardiovasc Pharmacol. 2000;35 (Suppl 3):S3-6

Ruilope LM. New clinical investigations with selective angiotensin II receptor blocker therapy in diabetes and renal disease. J Renin Angiotensin Aldosterone Syst. 2000;1(2 Suppl):S29-31.

Ruilope L. RAS blockade: new possibilities in the treatment of complications of diabetes. Heart. 2000;84(Suppl 1):i32-4:discussion i50

Ruilope LM, Aldigier JC, Ponticelli C, Oddou Stock P, Botteri F, Mann JF. Safety of the combination of valsartan and benazepril in patients with chronic renal disease. European Group for the Investigation of Valsartan in Chronic Renal Disease. J Hypertens. 2000;18(1):89-95.

Ruilope LM, Barrios V, Volpe M. Renal implications of the renin-angiotensin-aldosterone system blockade in heart failure. J Hypertens. 2000;18(11):1545-51

Suárez C, Ruilope LM. Hipertensión arterial: Cuanto más la conocemos peor la tratamos. Med Clin. 2000;114(10):379-80

Tena D, Abad JC, Lizasoaín M, Galán Dávila L, Sotelo T, Otero JR. Infiltrado pulmonar micronodular en un paciente con síndrome de inmunodeficiencia adquirida. Enferm Infecc Microbiol Clin. 2000;18(2):89-90